XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balances at Dec. 31, 2021 $ 74,512 $ 5 $ 24 $ 492,657 $ (11,134) $ (408,989) $ 1,949
Beginning Balances (in shares) at Dec. 31, 2021   5,000,000 22,230,000        
Net income (loss) (999)         (999)  
Unrealized income (loss) from foreign currency translation adjustments $ (175)           (175)
Issuance of common stock in connection with vesting of stock awards (shares) 88,000            
Stock-based compensation $ 895     895      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (399)       (399)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (18,000)        
Ending Balances at Mar. 31, 2022 73,834 $ 5 $ 24 493,552 (11,533) (409,988) 1,774
Ending Balances (in shares) at Mar. 31, 2022   5,000,000 22,300,000        
Beginning Balances at Dec. 31, 2022 75,394 $ 5 $ 24 495,818 (12,173) (409,381) 1,101
Beginning Balances (in shares) at Dec. 31, 2022   5,000,000 22,623,000        
Net income (loss) (2,719)         (2,719)  
Unrealized income (loss) from foreign currency translation adjustments 120           120
Issuance of common stock in connection with vesting of stock awards (shares)     78,000        
Stock-based compensation 990     990      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (184)       184    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (24,000)        
Ending Balances at Mar. 31, 2023 $ 73,601 $ 5 $ 24 $ 496,808 $ (12,357) $ (412,100) $ 1,221
Ending Balances (in shares) at Mar. 31, 2023   5,000,000 22,677,000